< Back to latest news & events

Event

HGF are Platinum Sponsors of the Dublin IP and R&D Summit

August 2024

HGF is proud to be Platinum sponsors of the IP and R&D Summit, taking place on the 4th and 5th of September 2024. This two day event will be held at the following venues:

Day 1Enterprise Ireland Offices, Ireland 

Day 2The Convention Centre Dublin, Ireland

On day 1, Craig Thomson will be moderating a panel session on: IP Strategy for SMEs and Innovators. This panel will discuss IP strategies for start-ups, focusing on safeguarding ideas and navigating legal complexities.

Panelists:

  • Craig Thomson, Partner & Patent Attorney, HGF
  • Eoin McManus, General Counsel, Klas
  • Pat Fitzgerald, CEO, Beotanics Ltd.
  • Michelle Tierney, Co-Founder & CSO, Mbryonics Ltd.
  • Donal O’Sullivan, CEO, Nutribio

Sean McDonagh will deliver a fireside chat on: Building a Brand Identity for Your Business, alongside Joe Doyle. They will explore how businesses can create and protect strong brand identities.

Sean will also be moderating a panel session on Day 2 of the event, on: Trade Mark Trends – Combating Counterfeiting and Navigating Dispute Resolution. This panel will cover strategies for trade mark protection, dispute resolution, and tackling AI-driven counterfeiting.

Panelists:

  • Sean McDonagh, Trade Mark Director, HGF
  • Ralf Duckeck, VP Intellectual Property, ebm-papst Group
  • Nancy Rowe, Global Head of Trade Marks, Bausch + Lomb
  • Pascal van Troost, Global Intellectual Property Director, Gates
  • Inge Buffollo, Director Business Development, EUIPO

HGF Partners Marie Walsh , Jason Lessard and Andrew McGettrick will also be attending and are looking forward to connecting with industry leaders at the event.

For more details, click the button below.

 

Latest updates

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

IP Ingredients: The not so "Impossible" Burger

Meat alternatives are a hot topic with the increase in popularity of vegetarianism and veganism, highlighted by this month being “veganuary”.  However, at time when meat alternatives are coming under …

Read article

WTR 1000 2025

We are proud to announce that our European trade mark team has been recognised in the World Trade Mark Review 1000 2025. The firm is also proud to have 19 …

Read article

Court of Appeal Confirms No Second Medical Use SPCs in UK

Merck Serono SA  v  The Comptroller-General of Patents, Designs, and Trade Marks – Lewison LJ, Arnold LJ and Birss LJ – [2025] EWCA Civ 45 – 28 January 2025 The …

Read article

T 0295/22: Apremilast decision highlights hopes and challenges for broad second medical use claims

This case provides insight to the EPO’s interpretation of administration features in second medical use claims. Whilst the door appears to be open for broader second medical use claims, they …

Read article

T 1418/22: Acalabrutinib provides guidance on establishing inventiveness of polymorphs at the EPO

The EPO Board of Appeal’s decision in T 1418/22 gives useful guidance on the inventiveness of polymorph claims in Europe. Starting from a known amorphous form, a specific crystalline form …

Read article

HGF Celebrates Two Nominations at the Women and Diversity in Law Awards

We are proud to share that we have been nominated for two awards at The Women and Diversity in Law Awards which will take place on 18th March at Hilton …

Read article